P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
Various testosterone inactivating pharmaceuticals (TIP) are used to treat prostate cancer. This post addresses Casodex (Bicalutamide) as a stand-alone therapy with the goal of reducing side effects commonly associated with …
Listen: https://soundcloud.com/prostate-oncology/hormone-therapy-tips “[Hormone therapy] is very effective for men with prostate cancer. Being a powerful treatment, you need to know how to use it, when to use it, and how …
How to Sequence Taxotere, Jevtana, Xtandi, and Zytiga By Mark Scholz, MD Since the advent of effective second-generation hormonal therapies such as Zytiga or Xtandi, prostate cancer experts have been …
BY MARK SCHOLZ, MD Hormones play a large role in cancer growth. They are also integral to treatment. Testosterone is a key player. It originates mostly in the testicles and, …
BY MARK SCHOLZ, MD The value of a new medical treatment is gauged by the seriousness of the problem it overcomes. Hormone-resistant prostate cancer—that is, prostate cancer that has become …
BY MARK SCHOLZ, MD Proton radiation is an enhanced type of radiation gaining in popularity for the treatment of prostate cancer. Men who are contemplating proton radiation need to compare …
BY MARK SCHOLZ, MD A certain question frequently arises in my daily medical practice. Patients ask, “I have a history of prostate cancer but my testosterone levels are low. Can I take …
BY MARK SCHOLZ, MD Avodart and Proscar are FDA-approved for treating urinary side effects from prostate enlargement. The generic name for Avodart is dutasteride; the generic name for Proscar is finasteride. These medications, …
BY MARK SCHOLZ, MD One cannot really talk intelligently about prostate cancer without a working knowledge of the PSA blood test. Most people are familiar with using PSA to diagnose prostate …
BY MARK SCHOLZ, MD It seems we have a national passion for prostate biopsies. A million men are biopsied every year. Two hundred thousand of them will be diagnosed with prostate cancer …